Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
SHREE GANESH REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2020Mar2019
   EV/Core EBITDA(x) 19.544.094.88

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 19.54 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.54
Mar20204.09
Mar20194.88

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 19.54
377.75
Mar2020 4.09
-16.19
Mar2019 4.88 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹968.3 Cr 5.4% 9% 22% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -4.6% 0.7% 10.8% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -1.2% 12.6% 51.2% Stock Analytics
CIPLA ₹122,717.0 Cr 0.7% 6% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1.8% -0.4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 4% 8.9% -1.3% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

5.4%

9%

22%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses